
    
      1. Study design: randomized double blind placebo controlled trial.

        2. Location and time of study: Geriatric Outpatient Clinic and Internal Medicine Outpatient
           Clinic in Cipto Mangunkusumo National Hospital Jakarta. Study will be conducted on April
           2016 to April 2017.

        3. Study subject: elderly outpatient (aged 60 years old or more) with pre-frail status, who
           visit the clinic for medical consultation.

        4. Data sampling: consecutive method.

        5. Sample size: 150 subjects (75 control group, 75 intervention group).

        6. Data collection: demographic data, frailty status, health related quality of life,
           anthropometric data, anti-oxidant serum status, hospitalization during intervention,
           morbidity, nutritional status, food intake, hand grip strength.

        7. Intervention: SOD+Gliadin in capsule with a dose of 250 mg twice a day for 24 weeks will
           be given to intervention group, while placebo group will be given placebo capsule
           (amylum).
    
  